Use of hmg fragments as anti-inflammatory agents
CA 2447576 C · Owner: The General Hospital Corporation · Inventors: Tracey, Kevin J.; Fink, Mitchell P.; Warren, Howland Shaw Jr.
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
Compositions and methods are disclosed for inhibiting the release of a proinflammatory cytokine from a vertebrate cell and for inhibiting an , inflammatory cytokine cascade in a patient. The compositions comprise a vertebrate HMG A box, and an antibody preparation that specifically binds to a vertebrate HMG B box. The methods comprise treating a cell or a patient with sufficient amounts of the composition to inhibit the release of the proinflammatory cytokine, or to inhibit the inflammatory cytokine cascade.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed May 15, 2002 and granted April 8, 2014. A Canadian patent filed from October 1, 1989 lasts 20 years from filing, so its term ended May 15, 2022.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by May 15, 2024.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.